|Environmental risk factors for Parkinson’s disease and parkinsonism: the Geoparkinson study|
FD Dick, G De Palma, A Ahmadi, NW Scott, GJ Prescott, J Bennett, ...
Occupational and environmental medicine 64 (10), 666-672, 2007
|Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity|
W Magliani, S Conti, F De Bernardis, M Gerloni, D Bertolotti, P Mozzoni, ...
Nature biotechnology 15 (2), 155-158, 1997
|Biomarkers of oxidative stress after controlled human exposure to ozone|
M Corradi, R Alinovi, M Goldoni, MV Vettori, G Folesani, P Mozzoni, ...
Toxicology letters 134 (1-3), 219-225, 2002
|Polymorphism of quinone-metabolizing enzymes and susceptibility to ozone-induced acute effects|
E Bergamaschi, G DE PALMA, P Mozzoni, S Vanni, MV VETTORI, ...
American journal of respiratory and critical care medicine 163 (6), 1426-1431, 2001
|Gene-environment interactions in parkinsonism and Parkinson’s disease: the Geoparkinson study|
FD Dick, G De Palma, A Ahmadi, A Osborne, NW Scott, GJ Prescott, ...
Occupational and environmental medicine 64 (10), 673-680, 2007
|Case-control study of interactions between genetic and environmental factors in Parkinson's disease|
G De Palma, P Mozzoni, A Mutti, S Calzetti, A Negrotti
The Lancet 352 (9145), 1986-1987, 1998
|Environmental and biological monitoring of benzene exposure in a cohort of Italian taxi drivers|
P Manini, G De Palma, R Andreoli, D Poli, P Mozzoni, G Folesani, A Mutti, ...
Toxicology letters 167 (2), 142-151, 2006
|Creatine as a compatible osmolyte in muscle cells exposed to hypertonic stress|
RR Alfieri, MA Bonelli, A Cavazzoni, M Brigotti, C Fumarola, P Sestili, ...
The Journal of physiology 576 (2), 391-401, 2006
|Occupational exposure to low levels of benzene: biomarkers of exposure and nucleic acid oxidation and their modulation by polymorphic xenobiotic metabolizing enzymes|
P Manini, G De Palma, R Andreoli, P Mozzoni, D Poli, M Goldoni, M Petyx, ...
Toxicology letters 193 (3), 229-235, 2010
|Oxidative and pro-inflammatory effects of cobalt and titanium oxide nanoparticles on aortic and venous endothelial cells|
R Alinovi, M Goldoni, S Pinelli, M Campanini, I Aliatis, D Bersani, ...
Toxicology in Vitro 29 (3), 426-437, 2015
|Glutathione S-transferases M1-1 and T1-1 as risk modifiers for renal cell cancer associated with occupational exposure to chemicals|
L Buzio, G De Palma, P Mozzoni, M Tondel, C Buzio, I Franchini, ...
Occupational and environmental medicine 60 (10), 789-793, 2003
|Plasma and EBC microRNAs as early biomarkers of non-small-cell lung cancer|
P Mozzoni, I Banda, M Goldoni, M Corradi, M Tiseo, O Acampa, ...
Biomarkers 18 (8), 679-686, 2013
|Polymorphism of xenobiotic-metabolizing enzymes and excretion of styrene-specific mercapturic acids|
G De Palma, P Manini, P Mozzoni, R Andreoli, E Bergamaschi, ...
Chemical research in toxicology 14 (10), 1393-1400, 2001
|Differential structural remodeling of the left‐atrial posterior wall in patients affected by mitral regurgitation with or without persistent atrial fibrillation: a …|
D Corradi, S Callegari, R Maestri, D Ferrara, D Mangieri, R Alinovi, ...
Journal of cardiovascular electrophysiology 23 (3), 271-279, 2012
|Correlation between erlotinib pharmacokinetics, cutaneous toxicity and clinical outcomes in patients with advanced non-small cell lung cancer (NSCLC)|
M Tiseo, R Andreoli, F Gelsomino, P Mozzoni, C Azzoni, M Bartolotti, ...
Lung cancer 83 (2), 265-271, 2014
|Metabolism of the EGFR tyrosin kinase inhibitor gefitinib by cytochrome P450 1A1 enzyme in EGFR-wild type non small cell lung cancer cell lines|
RR Alfieri, M Galetti, S Tramonti, R Andreoli, P Mozzoni, A Cavazzoni, ...
Molecular cancer 10 (1), 1-14, 2011
|Biomarkers of dose and susceptibility in cyclists exposed to monoaromatic hydrocarbons|
E Bergamaschi, A Brustolin, G De Palma, P Manini, P Mozzoni, ...
Toxicology letters 108 (2-3), 241-247, 1999
|Functional characterization of gefitinib uptake in non-small cell lung cancer cell lines|
M Galetti, RR Alfieri, A Cavazzoni, S La Monica, M Bonelli, C Fumarola, ...
Biochemical pharmacology 80 (2), 179-187, 2010
|A case‐control study of Parkinson's disease and tobacco use: Gene‐tobacco interactions|
G De Palma, FD Dick, S Calzetti, NW Scott, GJ Prescott, A Osborne, ...
Movement Disorders 25 (7), 912-919, 2010
|Biomarkers of nucleic acid oxidation, polymorphism in, and expression of, hOGG1 gene in styrene-exposed workers|
P Manini, G De Palma, R Andreoli, B Marczynski, M Hanova, P Mozzoni, ...
Toxicology letters 190 (1), 41-47, 2009